Welcome to the virtual GOLD GLP-1RA Masterclass Portal.
Please click on the videos below to access the recordings from our GOLD GLP-1RA Virtual Masterclass
Can we slow the progression of T2D?
Join A/Prof Gary Kilov as he presents a provocative discussion on whether it is possible to slow the progression of T2D. Gary will recap the pathophysiology of T2D and discuss the importance of glycaemic and weight management. What is the impact of early and intensive glycaemic and weight control and can intensive management delay the progression of T2D? Learn about the classes of T2D agents that may be most effective for managing T2D.
Deep dive into GLP-1 RAs: same-same but different?
Are all GLP-1RAs the same? What are the differences in clinical outcomes between available GLP-1RAs? Listen in to A/Prof Sarah Glastras as she takes a deep dive into the GLP-1RA class and discusses who when and why you might consider utilising a GLP-1RA for T2D management. Gain a comprehensive understanding of the mechanism of action of GLP-1RAs and discuss safety ‘myths and facts’ of this class of diabetes medications.
Prof Richard O’Brien
Welcome and introduction with Prof Richard O’Brien, Endocrinologist. Prof O’Brien provides an overview of the Virtual GOLD workshop program and how diabetes medications and guidelines have evolved, with a focus on GLP-1RAs.
Prof Richard O’Brien
A/Prof Sarah Glastras
A/Prof Gary Kilov
Catch up on the panel Q&A session with our expert speakers, and hear them answer audience questions on the clinical use of GLP-1RAs and Ozempic. What are the recommendations for treatment duration with Ozempic? Pregnancy? Why are there differences in cardiovascular outcomes with GLP-1RAs vs DPP4is? Tune in to hear the answers to these questions and more.
How do I know if my patient is right for a GLP-1 RA?
In this workshop, A/Prof Sarah Glastras, Endocrinologist, discusses a range of case studies to identify suitable patients for GLP-1RAs and Ozempic, including comorbidities and safety considerations.
Striking up a conversation
What is best practice when starting a GLP-1 RA?
Hear Kerry Porter, Credentialled Diabetes Educator and Nurse Practitioner, share best practice on how to discuss starting a GLP-1RA with a patient and address the potential injectable barrier. See a demonstration with the Ozempic pen and learn about dosing and managing side effects.
Navigating treatment combinations
What to do and what not to do?
Unsure about which combinations of diabetes medications can be used together with GLP-1RAs and Ozempic? Catch up on this workshop with A/Prof Gary Kilov, General Practitioner, as he discusses how to use Ozempic in combination with other type 2 diabetes agents. What are the PBS and safety considerations?
What would the expert do?
Prof Richard O’Brien, Endocrinologist, discusses a series of clinical case studies, with a focus on patients with comorbidities. Listen as he discusses suitability of Ozempic in patients with diabetes and CVD, renal impairment, hepatic impairment and in elderly patients.